Thalia Therapeutics

Be first to know our latest company updates

Watch exclusive videos accompanying major news

AIM Rule 26

Regulatory news

Why Invest

Presentations

Home

Media

Open Sans

THALIA THERAPEUTICS INVESTOR CENTRE

Our new animation displays how Nuvec’s® unique spiky structure and large surface area allow it to efficiently load, protect and deliver multiple siRNA to a target cell through endocytosis. Once delivered to the cytoplasm, the siRNA binds to the RNA-inducing silencing complex (RISC) to cut and degrade the specific mRNA, preventing it from becoming a functional protein.

Watch our animation to see Nuvec® in action:

Video: SiRNA transfection with Nuvec® and subsequent inhibition of mRNA translation